Trastuzumab deruxtecan for breast cancer: do patients experience a comprehensive benefit? Mosele F, Di Maio M. Ann Oncol 2023;34:567-568.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mosele F, Di Maio M. Trastuzumab deruxtecan for breast cancer: do patients experience a comprehensive benefit? Ann Oncol 2023;34:567-568.
PMID: 37349024